Stomach Cancer Trial, Recruiting (NCT05930860)

Stomach Cancer Trial, Recruiting NCT05930860 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05930860 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

You must be over 18 years old.
You have been diagnosed (through a camera examination of the stomach and tissue sample) with an early-stage stomach growth that can be removed using a specific non-surgical procedure called ESD, based on current medical guidelines.
You have a stomach growth that falls outside the usual guidelines for ESD removal, but you are not well enough to have surgery.

Who may not be able to join:

Your final test results show that the growth in your stomach is not actually cancerous or pre-cancerous (i.e., it turns out to be a non-harmful lesion).
You have a stomach growth that falls outside the usual guidelines for ESD removal, but you are fit enough to have surgery.
Scans or ultrasound examinations (when carried out) show that the disease has spread deeper into the stomach wall, or to nearby lymph nodes, or to other organs (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Federico Barbaro, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: 3921101013

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05930860

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Stomach Cancer

Trial contact: 3921101013

More information: https://clinicaltrials.gov/study/NCT05930860

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

You must be over 18 years old.
You have been diagnosed (through a camera examination of the stomach and tissue sample) with an early-stage stomach growth that can be removed using a specific non-surgical procedure called ESD, based on current medical guidelines.
You have a stomach growth that falls outside the usual guidelines for ESD removal, but you are not well enough to have surgery.

Who may not be able to join:

Your final test results show that the growth in your stomach is not actually cancerous or pre-cancerous (i.e., it turns out to be a non-harmful lesion).
You have a stomach growth that falls outside the usual guidelines for ESD removal, but you are fit enough to have surgery.
Scans or ultrasound examinations (when carried out) show that the disease has spread deeper into the stomach wall, or to nearby lymph nodes, or to other organs (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Registry

ClinicalTrials.gov

Start date

12 December 2021

Est. completion

12 August 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

En bloc resection rate; R0 resection rate; Curative resection rate; Complication rate; Recurrence rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov